Mochida Pharmaceutical Co Ltd 2023 Integrated Report

The report highlights Mochida Pharmaceutical Group's commitment to sustainable growth through its various business activities, including pharmaceuticals, biomaterials, and healthcare. It also outlines the company's efforts towards achieving its long-term vision, ""Vision for 2031,"" which focuses on developing new drug discovery modalities, expanding its biomaterials business, and promoting global expansion. The report further emphasizes the company's commitment to corporate governance, social responsibility, and environmental sustainability, detailing initiatives such as human resource development, compliance, ethical conduct, and environmental management.